Ngā hua rapu - Avner Schlessinger

Whakamahine hua
  1. 1
    Epitome: database of structure-inferred antigenic epitopes

    Epitome: database of structure-inferred antigenic epitopes mā Avner Schlessinger

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Protein flexibility and rigidity predicted from sequence

    Protein flexibility and rigidity predicted from sequence mā Avner Schlessinger, Burkhard Rost

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Automated Identification of Complementarity Determining Regions (CDRs) Reveals Peculiar Characteristics of CDRs and B Cell Epitopes

    Automated Identification of Complementarity Determining Regions (CDRs) Reveals Peculiar Characteristics of CDRs and B Cell Epitopes mā Yanay Ofran, Avner Schlessinger, Burkhard Rost

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Natively Unstructured Loops Differ from Other Loops

    Natively Unstructured Loops Differ from Other Loops mā Avner Schlessinger, Jinfeng Liu, Burkhard Rost

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Natively unstructured regions in proteins identified from contact predictions

    Natively unstructured regions in proteins identified from contact predictions mā Avner Schlessinger, Marco Punta, Burkhard Rost

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Protein secondary structure appears to be robust under<i>in silico</i>evolution while protein disorder appears not to be

    Protein secondary structure appears to be robust under<i>in silico</i>evolution while protein disorder appears not to be mā Christian Schaefer, Avner Schlessinger, Burkhard Rost

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Advances and Challenges in Rational Drug Design for SLCs

    Advances and Challenges in Rational Drug Design for SLCs mā Rachel‐Ann A. Garibsingh, Avner Schlessinger

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    SLC transporters: structure, function, and drug discovery

    SLC transporters: structure, function, and drug discovery mā Claire Colas, Peter M.U. Ung, Avner Schlessinger

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Targeting SLC transporters: small molecules as modulators and therapeutic opportunities

    Targeting SLC transporters: small molecules as modulators and therapeutic opportunities mā Avner Schlessinger, Nicole Zatorski, Keino Hutchinson, Claire Colas

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Molecular Modeling and Ligand Docking for Solute Carrier (SLC) Transporters

    Molecular Modeling and Ligand Docking for Solute Carrier (SLC) Transporters mā Avner Schlessinger, Natalia Khuri, Kathleen M. Giacomini, Andrej Šali

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    SLC Classification: An Update

    SLC Classification: An Update mā Avner Schlessinger, Sook Wah Yee, Andrej Šali, Kathleen M. Giacomini

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Improved Disorder Prediction by Combination of Orthogonal Approaches

    Improved Disorder Prediction by Combination of Orthogonal Approaches mā Avner Schlessinger, Marco Punta, Guy Yachdav, Laszló Kaján, Burkhard Rost

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Mutations in the Na+/Citrate Cotransporter NaCT (SLC13A5) in Pediatric Patients with Epilepsy and Developmental Delay

    Mutations in the Na+/Citrate Cotransporter NaCT (SLC13A5) in Pediatric Patients with Epilepsy and Developmental Delay mā Jenna Klotz, Brenda E. Porter, Claire Colas, Avner Schlessinger, Ana M. Pajor

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Identification of newborns at risk for autism using electronic medical records and machine learning

    Identification of newborns at risk for autism using electronic medical records and machine learning mā Rayees Rahman, Arad Kodesh, Stephen Z. Levine, Sven Sandin, Abraham Reichenberg, Avner Schlessinger

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Molecular Modeling of Drug–Transporter Interactions—An International Transporter Consortium Perspective

    Molecular Modeling of Drug–Transporter Interactions—An International Transporter Consortium Perspective mā Avner Schlessinger, Matthew A. Welch, Herman van Vlijmen, Ken Korzekwa, Peter W. Swaan, Pär Matsson

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening

    Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening mā Peter M.U. Ung, Wenxin Song, Lili Cheng, Xinbin Zhao, Hailin Hu, Ligong Chen, Avner Schlessinger

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Molecular Basis for Redox Activation of Epidermal Growth Factor Receptor Kinase

    Molecular Basis for Redox Activation of Epidermal Growth Factor Receptor Kinase mā Thu H. Truong, Peter M.U. Ung, Prakash B. Palde, Candice E. Paulsen, Avner Schlessinger, Kate S. Carroll

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET

    Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET mā Avner Schlessinger, Ethan G. Geier, Hao Fan, John J. Irwin, Brian K. Shoichet, Kathleen M. Giacomini, Andrej Šali

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1

    Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1 mā Ethan G. Geier, Avner Schlessinger, Hao Fan, Jonathan E. Gable, John J. Irwin, Andrej Šali, Kathleen M. Giacomini

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Correction: Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states

    Correction: Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states mā Andrea S. Heimann, Achla Gupta, Ivone Gomes, Rayees Rahman, Avner Schlessinger, Emer S. Ferro, Ellen M. Unterwald, Lakshmi A. Devi

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Errata/Corrigenda
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: